SURFHOPE® SE PHARMA (Product Description)

SURFHOPE® SE PHARMA (Product Description) 

 
SURFHOPE<sup>&reg;</sup>  SE PHARMA (Product Description)
 
Note: Surfhope SE pharma grades are strictly for Japan market only, recommend to replace it with similar food grade Ryoto sugar Esters for the same functions.

SURFHOPE®SE PHARMA are excellent non-ionic emulsifiers marketed by Mitsubishi-Kagaku Foods Corporation.They are highly refined Sucrose Fatty Acid Esters that can be used for many pharmaceutical applications. They are generally very mild to humans and are environmentally friendly.



All SURFHOPE® SE PHARMA, chemically known as Sucrose Fatty Acid Esters, have US Drug Master Files.


 

Type

HLB

Percentage of main fatty acid

Ester composition %

Form

Mono ester

Di,tri,poly ester

Sucrose stearate

D-1803

3

Approx.70

Approx.70

Approx.80

Powder

D-1803F

3

70

20

80

Powder

D-1805

5

70

30

70

Powder

D-1807

7

70

40

60

Powder

D-1809

9

70

50

50

Powder

D-1811

11

70

55

45

Powder

D-1811F

11

70

55

45

Powder

D-1815

15

70

70

30

Powder

D-1816

16

70

75

25

Powder

 

Sucrose palmitate

D-1615

15

80

70

30

Powder

D-1616

16

80

80

20

Powder

 

Sucrose laurate

D-1216

16

95

80

20

Pellet

 

[The functional properties of SURFHOPE® SE PHARMA]

   
   

<1. Hydration>

<2. Fat crystal control>


The affinity of SURFHOPE SE PHARMA for the water phase in an emulsion is derived from the hydroxyl groups (A) of the sucrose part of the molecule. Consequently SURFHOPE SE PHARMA yield emulsions which are exceptionally heat stable because the hydration of hydroxy groups is far stronger than the hydration of ether groups(B) in ethoxylated emulsifiers. SURFHOPE SE PHARMA can be used for heat stabilization and produce emulsions that are more heat stable than competing products,especially at higher temperatures.


Low HLB SURFHOPE SE PHARMA can modify the crystalline structure of solid triglycerides with useful benefits to the physical properties of the product.

 

 

 

<3. Oil in water emulsion>

<4. Tablet manufacturing>


SURFHOPE SE PHARMA, with medium-high hydrophilic-lipophilic balance(HLB), tend to form liquid crystal structures in aqueous solutions.
Because of their compact structure, SURFHOPE SE PHARMA coats the interfaces of emulsions very efficiently.


Low-medium HLB SURFHOPE SE PHARMA are not alkaline and are practically taste-free, a great advantage over magnesium stearate.

 






SURFHOPE ® SE PHARMA is a product of:
MITSUBISHI-KAGAKU FOODS CORPORATION

All data are extracts from www.mfc.co.jp
© 2005 Mitsubishi-Kagaku Foods Corporation. All Rights Reserved.

 

Distributors:
HALIM BIOTECH PTE LTD, Singapore
JUHALIM BIOTECH SDN BHD, Malaysia

   

For full print-out: click on [More Info ] below:



Quantity :    Enquiry